Medics Diary

NanoViricides, Inc., reported that it has signed a research and development agreement with Dr. Eva Harris laboratory at the University of California, Berkeley
Under this agreement, Dr. Harris and colleagues will evaluate the effectiveness of nanoviricides (R) drug candidates against various dengue virus. Cell culture models and in vivo animal studies will be used to [...]

Dengue hemorrhagic fever is an acute disease caused by one of the 4 serotypes of dengue virus, characterized by bleeding manifestations and tendentious can cause shock and death.
Approximately 2.5 billion people, or two-fifths of the world’s population, are now at risk from dengue.The disease is now endemic in over 100 countries.Dengue hemorrhagic fever is a [...]